This study is currently not recruiting participants.

Treatment Plan for Brincidofovir (CMX001 BCV) in a Named Patient with Adenovirus Infection

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

This is an expanded access treatment protocol for a single subject. The expanded access treatment program is for an investigational drug called brincidofovir (also known as CMX001) or "BCV" for short. The expanded access treatment program with BCV is being proposed to the subject as an experimental option for the treatment of the subject's virus infection.

Description

This is an expanded access treatment protocol for a single subject. The expanded access treatment program is for an investigational drug called brincidofovir (also known as CMX001) or "BCV" for short. The expanded access treatment program with BCV is being proposed to the subject as an experimental option for the treatment of the subject's virus infection.

Details
Condition Adenovirus Infection
Age 100years or below
Clinical Study IdentifierTX9042
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.